Division of General Surgery, Department of Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan City, Taiwan.
Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan City, Taiwan.
Front Endocrinol (Lausanne). 2023 Feb 3;14:1063837. doi: 10.3389/fendo.2023.1063837. eCollection 2023.
Secondary hyperparathyroidism (SHPT) is a common condition in patients with end-stage renal disease (ESRD) who are on dialysis. Parathyroidectomy is a treatment for patients when medical therapy has failed. Recurrence may occur and is indicated for further surgery in the era of improved quality of care for ESRD patients.
We identified, 1060 patients undergoing parathyroidectomy from January, 2011 to June, 2020. After excluding patients without regular check-up at our institute, primary hyperparathyroidism, or malignancy, 504 patients were enrolled. Sixty-two patients (12.3%, 62/504) were then excluded due to persistent SHPT even after the first parathyroidectomy. We aimed to identify risk factors for recurrent SHPT after the first surgery.
During the study period, 20% of patients who underwent parathyroidectomy at our institute (in, 2019) was due to recurrence after a previous parathyroidectomy. There were 442 patients eligible for analysis of recurrence after excluding patients with the persistent disease (n = 62). While 44 patients (9.95%) had recurrence, 398 patients did not. Significant risk factors for recurrent SHPT within 5 years after the first parathyroidectomy, including dialysis start time to first operation time < 3 years ( = 0.046), postoperative PTH >106.5 pg/mL ( < 0.001), and postoperative phosphorus> 5.9 mg/dL ( = 0.016), were identified by multivariate analysis.
The starting time of dialysis to first operation time < 3 years in the patients with dialysis, postoperative PTH> 106.5 pg/mL, and postoperative phosphorus> 5.9 mg/dL tended to have a higher risk for recurrent SHPT within 5 years after primary treatment.
继发性甲状旁腺功能亢进症(SHPT)是接受透析治疗的终末期肾病(ESRD)患者的常见病症。甲状旁腺切除术是药物治疗失败时的一种治疗方法。在 ESRD 患者的护理质量得到提高的时代,复发可能会发生,需要进一步手术。
我们从 2011 年 1 月至 2020 年 6 月期间,确定了 1060 例接受甲状旁腺切除术的患者。排除我院未定期检查、原发性甲状旁腺功能亢进症或恶性肿瘤的患者后,共纳入 504 例患者。由于初次甲状旁腺切除术后仍存在持续性 SHPT,62 例(12.3%,62/504)患者被排除在外。我们旨在确定初次手术后复发性 SHPT 的危险因素。
在研究期间,我院接受甲状旁腺切除术的患者中,有 20%(2019 年)是由于先前甲状旁腺切除术后复发。排除持续疾病患者(n=62)后,有 442 例患者符合分析复发的条件。44 例(9.95%)患者出现复发,398 例患者未复发。初次甲状旁腺切除术后 5 年内复发性 SHPT 的显著危险因素包括:透析开始至初次手术时间<3 年(=0.046)、术后甲状旁腺激素(PTH)>106.5pg/mL(<0.001)和术后磷>5.9mg/dL(=0.016),多因素分析得出。
透析开始至初次手术时间<3 年、术后 PTH>106.5pg/mL 和术后磷>5.9mg/dL 的患者在初次治疗后 5 年内复发性 SHPT 的风险较高。